Breaking News Instant updates and real-time market news.

CUB

Cubic

$51.60

4.8 (10.26%)

07:27
09/25/17
09/25
07:27
09/25/17
07:27

Cubic price target raised to $55 from $50 at Canaccord

Canaccord analyst Ken Herbert raised his price target on Cubic to $55 from $50 as he believes management will intensify its focus on execution and free cash flow, which he views as positives. He also noted its new CFO was upbeat on the opportunities outlined in the company's 2020 goals, including program execution, cash flow predictability and consistency, portfolio optimization, and cost reduction. Herbert reiterated his Buy rating on Cubic shares.

CUB Cubic
$51.60

4.8 (10.26%)

09/22/17
RAJA
09/22/17
UPGRADE
Target $60
RAJA
Strong Buy
Cubic upgraded to Strong Buy from Outperform at Raymond James
Raymond James analyst Brian Gesuale upgraded Cubic to Strong Buy from Outperform and raised its price target to $60 from $53. The analyst said, over the past four years, Cubic has foregone some near-term profits in order to establish the technical competencies, the reference contracts, and the past performance to accelerate its rebuilding process and drive significant shareholder value longer term. He now sees improving mix, accelerating organic growth, margin expansion, and news driven catalysts driving shares higher.
08/10/17
08/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cerner (CERN) upgraded to Equal Weight from Underweight at Morgan Stanley. 2. Stratasys (SSYS) upgraded to Buy from Neutral at Citi with analyst Kenneth Wong saying the company's fiscal 2017 targets are achievable following its "strong" second quarter results. The analyst lowered his price target for the shares to $29 from $32. 3. Vantiv (VNTV) upgraded to Buy from Hold at Stifel with analyst John Davis saying the company's acquisition of WorldPay is "transformative" and "a strategic home run." 4. Autohome (ATHM) was upgraded to Buy from Hold at Benchmark and Deutsche Bank. 5. Cubic (CUB) upgraded to Overweight from Neutral at JPMorgan with analyst Mark Strouse citing valuation with the shares down 14% since the third quarter report on August 3. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/17
JPMS
08/10/17
UPGRADE
Target $53
JPMS
Overweight
Cubic upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Mark Strouse upgraded Cubic to Overweight citing valuation with the shares down 14% since the Q3 report on August 3. The analyst views the pullback as overdone and keeps a $53 price target for the stock.
03/24/17
ADAM
03/24/17
NO CHANGE
Target $60
ADAM
Buy
Cubic price target raised to $60 from $54 at Canaccord
Canaccord analyst Ken Herbert raised his price target on Cubic to $60 from $54 following meetings with management. Herbert believes Cubic is uniquely positioned with material tailwinds for its business and the company's business mix is favorable considering the funding priorities of the Trump administration. The company is optimistic about winning the NYC subway contract estimated at over $1B over ten years, added Herbert, who reiterated his Buy rating on Cubic shares.

TODAY'S FREE FLY STORIES

LOGI

Logitech

$37.15

0.44 (1.20%)

05:27
10/24/17
10/24
05:27
10/24/17
05:27
Earnings
Logitech sees FY18 revenue up 10%-12% in constant currency »

Sees FY18 non-GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

LOGI

Logitech

$37.15

0.44 (1.20%)

05:26
10/24/17
10/24
05:26
10/24/17
05:26
Earnings
Logitech reports Q2 EPS 40c, consensus 35c »

Reports Q2 revenue $634M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ALXN

Alexion

$135.20

-3.82 (-2.75%)

05:25
10/24/17
10/24
05:25
10/24/17
05:25
Hot Stocks
Alexion announces FDA approval of Soliris »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

  • 06

    Nov

FFKT

Farmers Capital Bank

$44.00

0.2 (0.46%)

05:23
10/24/17
10/24
05:23
10/24/17
05:23
Hot Stocks
Farmers Capital Bank raises quarterly dividend by 2.5c to 12.5c per share »

Farmers Capital Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBTX

Veritex

$26.94

-0.17 (-0.63%)

05:21
10/24/17
10/24
05:21
10/24/17
05:21
Hot Stocks
Veritex announces branch office sales, terms not disclosed »

Veritex Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:19
10/24/17
10/24
05:19
10/24/17
05:19
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VECO

Veeco

$21.75

0.5 (2.35%)

05:18
10/24/17
10/24
05:18
10/24/17
05:18
Downgrade
Veeco rating change  »

Veeco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:16
10/24/17
10/24
05:16
10/24/17
05:16
Initiation
PQ Group initiated  »

PQ Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRTO

Criteo

$46.14

0.13 (0.28%)

, AAPL

Apple

$156.17

-0.08 (-0.05%)

05:15
10/24/17
10/24
05:15
10/24/17
05:15
Downgrade
Criteo, Apple rating change  »

Criteo downgraded to…

CRTO

Criteo

$46.14

0.13 (0.28%)

AAPL

Apple

$156.17

-0.08 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 02

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:10
10/24/17
10/24
05:10
10/24/17
05:10
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROX

Tronox

$26.58

0.25 (0.95%)

05:08
10/24/17
10/24
05:08
10/24/17
05:08
Initiation
Tronox initiated  »

Tronox initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:06
10/24/17
10/24
05:06
10/24/17
05:06
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$24.35

-2.82 (-10.38%)

05:04
10/24/17
10/24
05:04
10/24/17
05:04
Recommendations
Arconic analyst commentary  »

Arconic selloff yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:01
10/24/17
10/24
05:01
10/24/17
05:01
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ON

ON Semiconductor

$20.08

0.01 (0.05%)

04:59
10/24/17
10/24
04:59
10/24/17
04:59
Recommendations
ON Semiconductor analyst commentary  »

ON Semiconductor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TECH

Bio-Techne

$123.88

-0.37 (-0.30%)

04:58
10/24/17
10/24
04:58
10/24/17
04:58
Recommendations
Bio-Techne analyst commentary  »

Bio-Techne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 30

    Nov

ABT

Abbott

$56.08

-0.24 (-0.43%)

, DXCM

Dexcom

$44.77

-0.01 (-0.02%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Leerink medical devices analysts hold an analyst/industry conference call »

Analysts discuss…

ABT

Abbott

$56.08

-0.24 (-0.43%)

DXCM

Dexcom

$44.77

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 01

    Nov

  • 06

    Nov

JPM

JPMorgan

$99.34

-0.17 (-0.17%)

, C

Citi

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
eSHOW to hold a conference »

Money 20/20 is being held…

JPM

JPMorgan

$99.34

-0.17 (-0.17%)

C

Citi

CSCO

Cisco

$34.35

0.1 (0.29%)

BLK

BlackRock

$474.39

-2.23 (-0.47%)

BX

Blackstone

$34.72

0.26 (0.75%)

B

Barnes Group

$70.96

-0.93 (-1.29%)

BCS

Barclays

$10.27

-0.04 (-0.39%)

AMZN

Amazon.com

$966.30

-16.61 (-1.69%)

AKAM

Akamai

$51.46

-0.41 (-0.79%)

CS

Credit Suisse

$16.04

-0.06 (-0.37%)

DFS

Discover

$66.84

0.27 (0.41%)

IBM

IBM

$159.55

-2.52 (-1.55%)

INTC

Intel

$40.83

0.4 (0.99%)

SSNLF

Samsung

PAY

Verifone

$19.85

-0.21 (-1.05%)

MA

MasterCard

$145.56

0.18 (0.12%)

SPLK

Splunk

$64.23

0.14 (0.22%)

V

Visa

$107.53

-0.02 (-0.02%)

WFC

Wells Fargo

$54.91

-0.01 (-0.02%)

GOOG

Alphabet

$968.45

-19.75 (-2.00%)

MSFT

Microsoft

$78.83

0.02 (0.03%)

WMT

Wal-Mart

$88.65

1.21 (1.38%)

GS

Goldman Sachs

$242.13

-2.6 (-1.06%)

FB

Facebook

$171.27

-3.71 (-2.12%)

RY

Royal Bank of Canada

$80.19

-0.07 (-0.09%)

T

AT&T

$35.25

-0.29 (-0.82%)

JEF

Bought by LUK

ADBE

Adobe

$172.16

-3.48 (-1.98%)

BAC

Bank of America

$27.16

-0.01 (-0.04%)

DB

Deutsche Bank

$16.63

-0.35 (-2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 05

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 17

    Nov

  • 21

    Nov

  • 29

    Nov

  • 29

    Nov

  • 11

    Dec

  • 14

    Dec

  • 15

    Jan

  • 20

    Feb

  • 27

    Feb

  • 18

    Mar

  • 13

    Apr

  • 04

    May

  • 14

    Jul

  • 12

    Oct

MRK

Merck

$63.40

-0.48 (-0.75%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
World Congress to hold a summit »

5th Annual Patient…

MRK

Merck

$63.40

-0.48 (-0.75%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

PFE

Pfizer

$36.40

-0.02 (-0.05%)

AGN

Allergan

$187.77

-0.51 (-0.27%)

ONCE

Spark Therapeutics

$83.69

1.82 (2.22%)

PODD

Insulet

$61.02

-0.56 (-0.91%)

ACHN

Achillion

$4.01

-0.14 (-3.37%)

SNY

Sanofi

$49.62

0.11 (0.22%)

ABEO

Abeona Therapeutics

$18.60

-0.4 (-2.11%)

JNJ

Johnson & Johnson

$143.62

1.22 (0.86%)

AZN

AstraZeneca

$34.39

-0.23 (-0.66%)

SHPG

Shire

$144.78

-0.47 (-0.32%)

GSK

GlaxoSmithKline

$40.62

-0.22 (-0.54%)

BMY

Bristol-Myers

$63.75

-0.67 (-1.04%)

SCMP

Sucampo

$10.10

-0.2 (-1.94%)

PCRX

Pacira

$32.95

-0.55 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 28

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

  • 30

    Nov

  • 12

    Jan

  • 02

    Feb

  • 05

    Mar

  • 06

    Apr

FSBK

First South Bancorp

$18.99

0.33 (1.77%)

, CARO

Carolina Financial

$36.80

0.63 (1.74%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.99

0.33 (1.77%)

CARO

Carolina Financial

$36.80

0.63 (1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

ASOMY

ASOS

$73.88

-0.4 (-0.54%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
ASOS management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

AQXP

Aquinox

$12.47

-0.27 (-2.12%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Aquinox management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 07

    Dec

DDAIF

Daimler AG

$80.60

0.03 (0.04%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Daimler AG management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PAY

Verifone

$19.85

-0.21 (-1.05%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Verifone management to meet with Craig-Hallum »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 14

    Dec

04:55
10/24/17
10/24
04:55
10/24/17
04:55
General news
Breaking General news story  »

Week of 10/21 Redbook to…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.